Electrophoretical studies have shown that the negative surface charges of Ehrlich ascites tumor cells (7, 18) and osteogenic sarcoma cells (8, 17) decrease after treatment with RNase. Recent biochemical and immunological studies have shown that these RNase-susceptible, negatively charged groups on the surfaces of such nonleukemic ascites tumor cells as Ehrlich ascites tumor, sarcoma 180 and ascites hepatoma AH66F
Abbreviations used: TBS, tris-buffered saline (10 mM Tris-HC1 buffer, 137 mM NaCl, 3 mM KC1, 1 mM CaC12, and 0.5 mM MgC12, pH 7.0); FITC, fluorescein isothiocyanate; AMD, actinomycin D; PBS, phosphate-buffered saline (10 mM phosphate buffer, 137 mM NaC1, 3 mM KC1, 1 mM CaCl2, and 0.5 mM MgC12, pH 7.0).
are RNAs (15) that increase with the suppression of oxygen uptake when glucose is added to the cell suspension (9, 14) , a phenomenon known as the Crabtree effect (4). Normal mouse thymic cells and mouse leukemic ascites cells such as L1210, C1498, and T-3-C1-2, which show no Crabtree effect, have no RNA on their surfaces and do not change their surface negative charges on the addition of glucose (9, 14) . Presumably, the RNAs on cell surfaces have a marked effect on the surface negative charge in certain types of tumor cells (9) . RNA on the surface of Ehrlich ascites tumor cells has been shown to be a component of the cell surface membrane and to be released when the cells are treated with pronase (16) .
To determine the type of RNA on the surfaces of nonleukemic ascites tumor cells, we used two types of nonleukemic ascites tumor cells and two types of leukemic ascites cells that had been treated or not treated with pronase. We then extracted the RNAs from the cell supernatants and put them through sucrose density gradient centrifugation. 
RESULTS
Extraction of RNA from the surfaces of ascites tumor cells. To obtain RNA from their cell surfaces, two nonleukemic ascites tumor (Ehrlich and sarcoma 180) cells and two leukemic ascites (L1210 and C1498) cells were treated with pronase. After cell sedimentation, the RNA in the supernatant was fractionated by sucrose density gradient centrifugation. The absorptions at 260 nm of the RNA fractions released from nonleukemic Ehrlich ascites tumor cell surfaces is shown in Fig. 1A . Peaks containing 18S and 28S RNA were 80 higher in the RNA extracted from the supernatant of pronase-treated cells than in the peaks from non-treated cells. Sarcoma 180 cells gave the same results as Ehrlich ascites tumor cells (data not The effects of AMD on the electrophoretic mobility of Ehrlich ascites tumor cells are presented in Fig. 3 . Ehrlich ascites tumor cells that had been treated with AMD had lower surface negative charges than the nonAMD-treated controls. RNase treatment of nonAMD-treated Ehrlich ascites tumor cells produced a marked decrease in mobility, and RNase treatment of the AMD-treated Ehrlich ascites tumor cells decreased the mobility to that of the nonAMD-treated RNase treated cells. In contrast, L1210 cells showed no difference in the cell surface negative charges of AMD-treated cells and the nonAMD-treated controls (data not shown). Ehrlich ascites tumor cells that had been treated with AMD were, or were not, treated with pronase. RNA was extracted from their supernatants and put through sucrose density gradient ultracentrifugation.
The U.V. absorption spectra of the extracted RNAs is shown in Fig. 4 . The amount of the RNA extracted by pronase treatment of AMD-treated cells was only 20 % more than the values for the nonpronase-treated AMD-treated control cells ; but, the RNA extracted by pronase treatment of the nonAMD-treated cells was 80 more than that from the nonAMD-and nonpronase-treated cells. These results show 
